Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Intrathecal Administration of Autologous Mesenchymal Stem Cell-derived Neural Progenitors (MSC-NP) in Progressive Multiple Sclerosis

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03355365
Recruitment Status : Recruiting
First Posted : November 28, 2017
Last Update Posted : January 28, 2019
Sponsor:
Information provided by (Responsible Party):
Tisch Multiple Sclerosis Research Center of New York